Calcium abnormalities of dialysis patients.

作者信息

Fukagawa Masafumi, Akizawa Tadao

机构信息

Division of Nephrology and Dialysis Center, Kobe University School of Medicine, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan.

出版信息

J Bone Miner Metab. 2006;24(2):160. doi: 10.1007/s00774-005-0663-y.

DOI:10.1007/s00774-005-0663-y

PMID:16502124

Abstract

摘要

相似文献

Calcium abnormalities of dialysis patients.

J Bone Miner Metab. 2006;24(2):160. doi: 10.1007/s00774-005-0663-y.

Vitamin D, parathyroid hormone, and calcium: a complex regulatory network.

Am J Med. 1999 Dec;107(6):637-9. doi: 10.1016/s0002-9343(99)00283-1.

The case for parathyroid hormone.

Am J Kidney Dis. 1985 Nov;6(5):306-8. doi: 10.1016/s0272-6386(85)80084-6.

[Bone and Calcium Research Update 2015. Regulation of calcium in CKD].

Clin Calcium. 2015 Jan;25(1):79-85.

[Renal osteodystrophy-II-Recent therapeutic acquisitions (author's transl)].

Nouv Presse Med. 1977 Nov 12;6(38):3533-7.

Calcium homeostasis and imbalance.

Nephron. 2002;92 Suppl 1:41-5. doi: 10.1159/000065376.

Contribution of intestine, bone, kidney, and dialysis to extracellular fluid calcium content.

Clin J Am Soc Nephrol. 2010 Jan;5 Suppl 1:S12-22. doi: 10.2215/CJN.05970809.

Role of PTH, vitamin D and bone metabolism in low protein-induced hypercalciuria.

Adv Exp Med Biol. 1986;208:199-204. doi: 10.1007/978-1-4684-5206-8_24.

[Glucocorticoids and calcium metabolism regulation].

Ter Arkh. 1984;56(3):137-41.

[Problems in mineral and bone metabolism in chronic renal insufficiency].

Probl Actuels Endocrinol Nutr. 1977(20):175-86.

引用本文的文献

Clinical significance of parathyroid intervention on CKD-MBD management.

NDT Plus. 2008 Aug;1(Suppl 3):iii9-iii13. doi: 10.1093/ndtplus/sfn080.

CKD-MBD: impact on management of kidney disease.

Clin Exp Nephrol. 2007 Dec;11(4):261-268. doi: 10.1007/s10157-007-0492-5. Epub 2007 Dec 21.

The kidney and bone metabolism: Nephrologists' point of view.

J Bone Miner Metab. 2006;24(6):434-8. doi: 10.1007/s00774-006-0719-7.

Regulation of parathyroid function in chronic kidney disease (CKD).

Clin Exp Nephrol. 2006 Sep;10(3):175-9. doi: 10.1007/s10157-006-0432-9.

本文引用的文献

Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study.

Kidney Int. 2005 Mar;67(3):1179-87. doi: 10.1111/j.1523-1755.2005.00185.x.

An overview of regular dialysis treatment in Japan (as of 31 December 2001).

Ther Apher Dial. 2004 Feb;8(1):3-32. doi: 10.1111/j.1526-0968.2004.00109.x.

K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.

Am J Kidney Dis. 2003 Oct;42(4 Suppl 3):S1-201.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Calcium abnormalities of dialysis patients.

J Bone Miner Metab. 2006;24(2):160. doi: 10.1007/s00774-005-0663-y.

Vitamin D, parathyroid hormone, and calcium: a complex regulatory network.

Am J Med. 1999 Dec;107(6):637-9. doi: 10.1016/s0002-9343(99)00283-1.

The case for parathyroid hormone.

Am J Kidney Dis. 1985 Nov;6(5):306-8. doi: 10.1016/s0272-6386(85)80084-6.

[Bone and Calcium Research Update 2015. Regulation of calcium in CKD].

Clin Calcium. 2015 Jan;25(1):79-85.

[Renal osteodystrophy-II-Recent therapeutic acquisitions (author's transl)].

Nouv Presse Med. 1977 Nov 12;6(38):3533-7.

Calcium homeostasis and imbalance.

Nephron. 2002;92 Suppl 1:41-5. doi: 10.1159/000065376.

Contribution of intestine, bone, kidney, and dialysis to extracellular fluid calcium content.

Clin J Am Soc Nephrol. 2010 Jan;5 Suppl 1:S12-22. doi: 10.2215/CJN.05970809.

Role of PTH, vitamin D and bone metabolism in low protein-induced hypercalciuria.

Adv Exp Med Biol. 1986;208:199-204. doi: 10.1007/978-1-4684-5206-8_24.

[Glucocorticoids and calcium metabolism regulation].

Ter Arkh. 1984;56(3):137-41.

[Problems in mineral and bone metabolism in chronic renal insufficiency].

Probl Actuels Endocrinol Nutr. 1977(20):175-86.

引用本文的文献

Clinical significance of parathyroid intervention on CKD-MBD management.

NDT Plus. 2008 Aug;1(Suppl 3):iii9-iii13. doi: 10.1093/ndtplus/sfn080.

CKD-MBD: impact on management of kidney disease.

Clin Exp Nephrol. 2007 Dec;11(4):261-268. doi: 10.1007/s10157-007-0492-5. Epub 2007 Dec 21.

The kidney and bone metabolism: Nephrologists' point of view.

J Bone Miner Metab. 2006;24(6):434-8. doi: 10.1007/s00774-006-0719-7.

Regulation of parathyroid function in chronic kidney disease (CKD).

Clin Exp Nephrol. 2006 Sep;10(3):175-9. doi: 10.1007/s10157-006-0432-9.

本文引用的文献

Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study.

Kidney Int. 2005 Mar;67(3):1179-87. doi: 10.1111/j.1523-1755.2005.00185.x.

An overview of regular dialysis treatment in Japan (as of 31 December 2001).

Ther Apher Dial. 2004 Feb;8(1):3-32. doi: 10.1111/j.1526-0968.2004.00109.x.

K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.

Am J Kidney Dis. 2003 Oct;42(4 Suppl 3):S1-201.